<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Novavax Inc. NVAX, -1.14% and Serum Institute of India said Wednesday that the Philippine Food and Drug Administration has granted emergency use authorization to Novavax’ COVID-19 vaccine with Matrix-M(TM) adjuvant. The vaccine will be made in the Philippines by the SII under the brand name Covovax.
...read full article on Market Watch
